References

Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-Loaded Lipid Nanoparticles

10.1002/adhm.202202528 · ExternalCitation · doi-reference

Glucose–Nucleobase Pseudo Base Pairs: Biomolecular Interactions within DNA

10.1002/anie.201603510 · ExternalCitation · doi-reference

Age-related changes in central nervous system phosphatidylserine decarboxylase activity

10.1002/jnr.10385 · ExternalCitation · doi-reference

Phosphatidylserine in the Nervous System: Cytoplasmic Regulator of the AKT and PKC Signaling Pathways and Extracellular “Eat-Me” Signal in Microglial Phagocytosis

10.1007/s12035-022-03133-6 · ExternalCitation · doi-reference

Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics

10.1016/j.copbio.2023.103049 · ExternalCitation · doi-reference

Incorporation of phosphatidylserine improves efficiency of lipid based gene delivery systems

10.1016/j.ejpb.2022.02.007 · ExternalCitation · doi-reference

Phosphatidylserine-decorated delivery platform helps alleviate acute lung injury via potentiating macrophage targeting

10.1016/j.jlr.2025.100799 · ExternalCitation · doi-reference

Fabrication of active targeting lipid nanoparticles: Challenges and perspectives

10.1016/j.mtadv.2022.100299 · ExternalCitation · doi-reference

Phosphatidylserine (PS) and phosphatidylglycerol (PG) nanodispersions as potential anti-inflammatory therapeutics: Comparison of in vitro activity and impact of pegylation

10.1016/j.nano.2019.102096 · ExternalCitation · doi-reference

20(S)-protopanaxadiol targets brain-enriched adenylate kinase 5 to improve cognitive function via regulating hippocampal neural plasticity

10.1016/j.phymed.2025.157711 · ExternalCitation · doi-reference

Phosphatidylserine in the brain: Metabolism and function

10.1016/j.plipres.2014.06.002 · ExternalCitation · doi-reference

Protocol for formulation and evaluation of phytosterol-based lipid nanoparticles as cholesterol alternatives for mRNA delivery

10.1016/j.xpro.2026.104392 · ExternalCitation · doi-reference

Carbohydrate-nucleotide interaction The effects of mono- and disaccharides on the solution structure of AMP, dAMP, ATP, GMP, dGMP, and GTP studied by FTIR difference spectroscopy

10.1016/s0162-0134(96)00097-9 · ExternalCitation · doi-reference

Lipid Nanoparticles for Brain Tumor Theranostics: Challenges and Status

10.1021/acs.bioconjchem.4c00293 · ExternalCitation · doi-reference

Protective Effect of 20(S)-Protopanaxadiol on D-Gal-Induced Cognitively Impaired Mice Based on Its Target Protein Brain-type Creatine Kinase

10.1021/acs.jafc.2c07889 · ExternalCitation · doi-reference

Enhancing the Endocytosis of Phosphatidylserine-Containing Liposomes through Tim4 by Modulation of Membrane Fluidity

10.1021/acs.molpharmaceut.1c00645 · ExternalCitation · doi-reference

Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs

10.1021/acs.nanolett.2c03234 · ExternalCitation · doi-reference

Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain

10.1021/acs.nanolett.4c05186 · ExternalCitation · doi-reference

Exploring the Effects of Incorporating Different Bioactive Phospholipids into Messenger Ribonucleic Acid Lipid Nanoparticle (mRNA LNP) Formulations

10.1021/acsbiomedchemau.4c00085 · ExternalCitation · doi-reference

Microbiome-Derived Lipid Nanoparticles for Improved Immunogenicity of mRNA Vaccines

10.1021/acsmaterialslett.3c01642 · ExternalCitation · doi-reference

Curcumin-Loaded Biohybrid Nanoparticles Modulating Inflammation and Reducing Lipid Accumulation in Atherosclerotic Plaques for Atherosclerosis Treatment

10.1021/acsmaterialslett.5c01506 · ExternalCitation · doi-reference

AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism

10.1021/acsnano.4c15013 · ExternalCitation · doi-reference

High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain

10.1021/acsnano.5c19138 · ExternalCitation · doi-reference

Post-Conjugation Process for Antibody-Conjugated Lipid Nanoparticles Enabling Tunable Antibody Surface Density for Targeted RNA Delivery

10.1021/acsnano.5c21719 · ExternalCitation · doi-reference

Design and Targeting Strategies in Nanotheranostics for Glioma

10.1021/acsnanomed.5c00071 · ExternalCitation · doi-reference

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

10.1038/s41392-024-02002-z · ExternalCitation · doi-reference

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system

10.1038/s41563-024-02114-5 · ExternalCitation · doi-reference

The role of phosphatidylserine in recognition of apoptotic cells by phagocytes

10.1038/sj.cdd.4400404 · ExternalCitation · doi-reference

Strategies and challenges to improve the performance of tumor-associated active targeting

10.1039/d0tb00289e · ExternalCitation · doi-reference

Formulation of lipid nanoparticles containing ginsenoside Rg2 and protopanaxadiol for highly efficient delivery of mRNA

10.1039/d4bm01070a · ExternalCitation · doi-reference

A new strategy for the extrahepatic delivery of lipid-based nanomedicines: a protein corona-mediated selective targeting system based on an ionizable cationic lipid library

10.1039/d5pm00079c · ExternalCitation · doi-reference

On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles

10.1073/pnas.2109256118 · ExternalCitation · doi-reference

Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles

10.1080/08820139.2020.1738456 · ExternalCitation · doi-reference

The role of phosphatidylserine recognition receptors in multiple biological functions

10.1186/s11658-020-00214-z · ExternalCitation · doi-reference

The blood–brain barriers: novel nanocarriers for central nervous system diseases

10.1186/s12951-025-03247-8 · ExternalCitation · doi-reference